Obio Technology (688238.SH) announced a pre-tax loss, with an estimated net loss of 282 million to 339 million yuan in 2024.
He Yuan Biotechnology (688238.SH) announced that, according to preliminary calculations by the finance department, the company is expected to achieve...
Obio Technology (688238.SH) announced that, according to preliminary calculations by the finance department, the company is expected to achieve annual operating income of 236.00 million yuan to 262.00 million yuan in 2024, an increase of 31.195 million yuan to 57.195 million yuan compared to the same period last year, with a year-on-year growth of 15.23% to 27.93%.
The company expects to achieve a net profit attributable to the owners of the parent company of -339.00 million yuan to -282.00 million yuan in 2024, an increase in loss of 154.06 million yuan to 211.06 million yuan compared to the same period last year.
The company expects to achieve a net profit attributable to the owners of the parent company, excluding non-recurring gains and losses, of -352.00 million yuan to -292.00 million yuan in 2024, an increase in loss of 158.45 million yuan to 218.45 million yuan compared to the same period last year.
Related Articles

Guosen: The final mindset of asset trend convergence.

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.
Guosen: The final mindset of asset trend convergence.

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


